Details for New Drug Application (NDA): 050750
✉ Email this page to a colleague
NDA 050750 describes ZOSYN IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare Corp and is included in one NDA. It is available from two suppliers. Additional details are available on the ZOSYN IN PLASTIC CONTAINER profile page.
The generic ingredient in ZOSYN IN PLASTIC CONTAINER is piperacillin sodium; tazobactam sodium. There are sixteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.
The generic ingredient in ZOSYN IN PLASTIC CONTAINER is piperacillin sodium; tazobactam sodium. There are sixteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.
Summary for 050750
| Tradename: | ZOSYN IN PLASTIC CONTAINER |
| Applicant: | Baxter Hlthcare Corp |
| Ingredient: | piperacillin sodium; tazobactam sodium |
| Patents: | 0 |
Pharmacology for NDA: 050750
| Mechanism of Action | beta Lactamase Inhibitors |
Suppliers and Packaging for NDA: 050750
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ZOSYN IN PLASTIC CONTAINER | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 050750 | NDA | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 0206-8860 | 0206-8860-02 | 24 BAG in 1 BOX (0206-8860-02) / 50 mL in 1 BAG (0206-8860-01) |
| ZOSYN IN PLASTIC CONTAINER | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 050750 | NDA | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 0206-8861 | 0206-8861-02 | 24 BAG in 1 BOX (0206-8861-02) / 50 mL in 1 BAG (0206-8861-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 40MG BASE/ML;EQ 5MG BASE/ML | ||||
| Approval Date: | Feb 24, 1998 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 60MG BASE/ML;EQ 7.5MG BASE/ML | ||||
| Approval Date: | Feb 24, 1998 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 4GM BASE/100ML;EQ 500MG BASE/100ML | ||||
| Approval Date: | Feb 24, 1998 | TE: | RLD: | Yes | |||||
Expired US Patents for NDA 050750
Complete Access Available with Subscription
